Detalhe da pesquisa
1.
Metformin Promotes Antitumor Immunity via Endoplasmic-Reticulum-Associated Degradation of PD-L1.
Mol Cell
; 71(4): 606-620.e7, 2018 08 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-30118680
2.
A phase II study of neoadjuvant atezolizumab and nab-paclitaxel in patients with anthracycline-resistant early-stage triple-negative breast cancer.
Breast Cancer Res Treat
; 199(3): 457-469, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37061619
3.
Early-stage Triple-negative Breast Cancer: Time to Optimize Personalized Strategies.
Oncologist
; 27(1): 30-39, 2022 02 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35305094
4.
Quantitative Apparent Diffusion Coefficients From Peritumoral Regions as Early Predictors of Response to Neoadjuvant Systemic Therapy in Triple-Negative Breast Cancer.
J Magn Reson Imaging
; 56(6): 1901-1909, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35499264
5.
Palbociclib with adjuvant endocrine therapy in early breast cancer (PALLAS): interim analysis of a multicentre, open-label, randomised, phase 3 study.
Lancet Oncol
; 22(2): 212-222, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33460574
6.
Early ultrasound evaluation identifies excellent responders to neoadjuvant systemic therapy among patients with triple-negative breast cancer.
Cancer
; 127(16): 2880-2887, 2021 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33878210
7.
Tumor necrosis by pretreatment breast MRI: association with neoadjuvant systemic therapy (NAST) response in triple-negative breast cancer (TNBC).
Breast Cancer Res Treat
; 185(1): 1-12, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-32920733
8.
A phase II study of Mirvetuximab Soravtansine in triple-negative breast cancer.
Invest New Drugs
; 39(2): 509-515, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32984932
9.
Functional Tumor Volume by Fast Dynamic Contrast-Enhanced MRI for Predicting Neoadjuvant Systemic Therapy Response in Triple-Negative Breast Cancer.
J Magn Reson Imaging
; 54(1): 251-260, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33586845
10.
A comprehensive overview of metaplastic breast cancer: clinical features and molecular aberrations.
Breast Cancer Res
; 22(1): 121, 2020 11 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33148288
11.
Comparison of three scoring methods using the FDA-approved 22C3 immunohistochemistry assay to evaluate PD-L1 expression in breast cancer and their association with clinicopathologic factors.
Breast Cancer Res
; 22(1): 69, 2020 06 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-32576238
12.
A phase Ib study of entinostat plus lapatinib with or without trastuzumab in patients with HER2-positive metastatic breast cancer that progressed during trastuzumab treatment.
Br J Cancer
; 120(12): 1105-1112, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31097774
13.
Palbociclib and Letrozole in Advanced Breast Cancer.
N Engl J Med
; 375(20): 1925-1936, 2016 11 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-27959613
14.
Adaptive Randomization of Neratinib in Early Breast Cancer.
N Engl J Med
; 375(1): 11-22, 2016 Jul 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27406346
15.
Adaptive Randomization of Veliparib-Carboplatin Treatment in Breast Cancer.
N Engl J Med
; 375(1): 23-34, 2016 Jul 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27406347
16.
Lapatinib activity in metastatic human epidermal growth factor receptor 2-positive breast cancers that received prior therapy with trastuzumab, pertuzumab, and/or ado-trastuzumab emtansine (T-DM1).
Breast Cancer Res Treat
; 176(1): 227-234, 2019 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-30977027
17.
Efficacy and safety of the combination of metformin, everolimus and exemestane in overweight and obese postmenopausal patients with metastatic, hormone receptor-positive, HER2-negative breast cancer: a phase II study.
Invest New Drugs
; 37(2): 345-351, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30610588
18.
Development of CNS metastases and survival in patients with inflammatory breast cancer.
Cancer
; 124(11): 2299-2305, 2018 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29579338
19.
Comparative Effectiveness of an mTOR-Based Systemic Therapy Regimen in Advanced, Metaplastic and Nonmetaplastic Triple-Negative Breast Cancer.
Oncologist
; 23(11): 1300-1309, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30139837
20.
Adjuvant versus neoadjuvant chemotherapy in triple-negative breast cancer patients with BRCA mutations.
Breast Cancer Res Treat
; 170(1): 101-109, 2018 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-29470805